fda glp-1 warning news november 2025 Weight-Loss Drug Demonstration Begins July 2026 September 8, 2025: FDA launches

By Ann Czarnik, M.D., FACEP Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health If youre researching GLP-1 weight loss medications , youve probably run into a confusing divide

Takes Time, But It Works Emily R., New York It wasnt instant, and the first few weeks were mostly about adjusting

Alpha-glucosidase is an enzyme in the digestive system that facilitates the breakdown of dietary starches into simple sugars for intestinal absorption

The enzyme dipeptidyl peptidase-4 (DPP-4) rapidly degrades circulating GLP-1, which is why pharmaceutical versions are chemically modified to resist this breakdown and maintain therapeutic levels for extended periods